Sunday, May 31, 2026Aggregating 2,418 sources · Updated 38 seconds agoNYC 54° · LON 47° · TOK 61°
Front PageWorld NewsINDEPENDENT
World News

Daily pill almost doubles survival time for pancreatic cancer patients in new trial

INDEPENDENT·3h ago·3 min read
Photograph via Independent
RSS SUMMARY · AGGREGATED FROM INDEPENDENT

Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease

Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease

Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease

Continue Reading

The full story continues on Independent.

Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.